Application of fluorescent tracer agent technology to point-of-care gastrointestinal permeability measurement

Richard B. Dorshow; Jeng-Jong Shieh; Thomas E. Rogers; Carla Hall-Moore; Nurmohammad Shaikh; Michael Talcott; Phillip I. Tarr

doi:10.1117/12.2211790

22 April 2016 Application of fluorescent tracer agent technology to point-of-care gastrointestinal permeability measurement

Richard B. Dorshow, Jeng-Jong Shieh, Thomas E. Rogers, Carla Hall-Moore, Nurmohammad Shaikh, Michael Talcott, Phillip I. Tarr

Author Affiliations +

Proceedings Volume 9723, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications VIII; 97230A (2016) https://doi.org/10.1117/12.2211790
Event: SPIE BiOS, 2016, San Francisco, California, United States

Abstract

Gut dysfunction, often accompanied by increased mucosal permeability to gut contents, frequently accompanies a variety of human intestinal inflammatory conditions. These disorders include inflammatory bowel diseases (e.g., Crohn’s Disease) and environmental enteropathy and enteric dysfunction, a condition strongly associated with childhood malnutrition and stunting in resource poor areas of the world. The most widely used diagnostic assay for gastrointestinal permeability is the lactulose to mannitol ratio (L:M) measurement. These sugars are administered orally, differentially absorbed by the gut, and then cleared from the body by glomerular filtration in the kidney. The amount of each sugar excreted in the urine is measured. The larger sugar, lactulose, is minimally absorbed through a healthy gut. The smaller sugar, mannitol, in contrast, is readily absorbed through both a healthy and injured gut. Thus a higher ratio of lactulose to mannitol reflects increased intestinal permeability. However, several issues prevent widespread use of the L:M ratio in clinical practice. Urine needs to be collected over time intervals of several hours, the specimen then needs to be transported to an analytical laboratory, and sophisticated equipment is required to measure the concentration of each sugar in the urine. In this presentation we show that fluorescent tracer agents with molecular weights similar to those of the sugars, selected from our portfolio of biocompatible renally cleared fluorophores, mimic the L:M ratio test for gut permeability. This fluorescent tracer agent detection technology can be used to overcome the limitations of the L:M assay, and is amenable to point-of-care clinical use.

Citation Download Citation

Richard B. Dorshow, Jeng-Jong Shieh, Thomas E. Rogers, Carla Hall-Moore, Nurmohammad Shaikh, Michael Talcott, and Phillip I. Tarr "Application of fluorescent tracer agent technology to point-of-care gastrointestinal permeability measurement", Proc. SPIE 9723, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications VIII, 97230A (22 April 2016); https://doi.org/10.1117/12.2211790

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available